Market Overview

Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry With The Highest Revenue Estimates

Share:
Related ALR
20 Stocks Moving In Wednesday's Pre-Market Session
Benzinga's Top Upgrades
Related ICLR
ICON May Miss Revenue Guidance, But Baird Still Bullish
A Peek Into The Markets: U.S. Stock Futures Slide Ahead Of Consumer Sentiment Report
Is Medpace The Next Healthcare IPO Big Winner? (Seeking Alpha)

Below are the top small-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of revenue estimate for the current year.

Analysts expect Alere (NYSE: ALR) to post revenue of $2.78 billion for the year ending December, 2012. Alere had $303.15 million in total cash for the latest quarter.

ICON Public Limited Company (NASDAQ: ICLR) is likely to post revenue of $1.10 billion in the year ending December, 2012. ICON's trailing-twelve-month operating margin is 5.29%.

Bio-Reference Laboratories (NASDAQ: BRLI) may report revenue of $651.40 million in the current year. Bio-Reference Laboratories' PEG ratio is 0.90.

Alliance Healthcare Services (NYSE: AIQ) is expected to report revenue of $487.02 million for the year ending December, 2012. Alliance Healthcare's trailing-twelve-month ROA is 4.51%.

Posted-In: Highest Revenue Estimates Medical Laboratories & Research Industry small-cap stocksTrading Ideas

 

Related Articles (AIQ + ALR)

View Comments and Join the Discussion!